| |
Units
|
Total
|
Attack
|
Remission
|
Acute MY subgroup
|
Acute ON subgroup
|
Acute BRAIN subgroup
|
|---|
|
a. Based on QIg > Qlim(Ig)
|
|
3-class reaction
|
Samples
|
1/107 (0.9%)
|
1/81 (1.2%)
|
0/19 (0%)
|
1/38 (2.6%)
|
0/36 (0%)
|
0/6 (0%)
|
|
2-class reaction
|
Samples
|
5/107 (4.7%)
|
4/81 (4.9%)
|
1/19 (5.3%)
|
2/38 (5.3%)
|
2/36 (5.6%)
|
0/6 (0%)
|
|
IgG + IgM
|
Samples
|
3/107 (2.8%)
|
3/81 (3.7%)
|
0/19 (0%)
| | | |
|
IgG + IgA
|
Samples
|
2/107 (1.9%)
|
1/81 (1.2%)
|
1/19 (5.3%)
| | | |
|
IgM + IgA
|
Samples
|
0/107 (0%)
|
0/81 (0%)
|
0/19 (0%)
| | | |
|
1-class reaction
|
Samples
|
15/107 (14%)
|
15/81 (18.5%)
|
0/19 (0%)
|
10/38 (26.3%)
|
3/36 (8.3%)
|
2/6 (33.3%)
|
|
Only IgG
|
Samples
|
4/107 (3.7%)
|
4/81 (4.9%)
|
0/19 (0%)
| | | |
|
Only IgM
|
Samples
|
9/107 (8.4%)
|
9/81 (11.1%)
|
0/19 (0%)
| | | |
|
Only IgA
|
Samples
|
2/107 (1.9%)
|
2/81 (2.5%)
|
0/19 (0%)
| | | |
|
b. Based on Ig-IF > 10%
|
|
3-class reaction#
|
Samples
|
1/107 (0.9%)
|
1/81 (1.2%)
|
0/19 (0%)
|
1/38 (2.6%)
|
0/36 (0%)
|
0/6 (0%)
|
|
2-class reaction§
|
Samples
|
1/107 (0.9%)
|
1/81 (1.2%)
|
0/19 (0%)
|
1/38 (2.6%)
|
0/36 (0%)
|
0/6 (0%)
|
|
IgG + IgM
|
Samples
|
1/107 (0.9%)
|
1/81 (1.2%)
|
0/19 (0%)
| | | |
|
IgG + IgA
|
Samples
|
0/107 (0%)
|
0/81 (0%)
|
0/19 (0%)
| | | |
|
IgM + IgA
|
Samples
|
0/107 (0%)
|
0/81 (0%)
|
0/19 (0%)
| | | |
|
1-class reaction
|
Samples
|
9/107 (8.4%)
|
8/81 (9.9%)
|
1/19 (5.3%)
|
3/38 (7.9%)
|
4/36 (11.1%)
|
1/6 (16.7%)
|
|
Only IgG
|
Samples
|
3/107 (2.8%)
|
3/81 (3.7%)
|
0/19 (0%)
| | | |
|
Only IgM
|
Samples
|
4/107 (3.7%)
|
4/81 (4.9%)
|
0/19 (0%)
| | | |
|
Only IgA
|
Samples
|
2/107 (1.9%)
|
1/81 (1.2%)
|
1/19 (5.3%)
| | | |
- #IF in the single sample with a three-class reaction: IgG-IF 18.79%, IgM-IF 21.65% and IgA-IF 31%
- §IF in the single sample with a two-class reaction: IgG-IF 33.09% and IgM-IF 59%
